New Drug Combo for ALS Slows Decline in Small Clinical Study
New Drug Combo for ALS Slows Decline in Small Clinical Study
After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.
New Drug Combo for ALS Slows Decline in Small Clinical Study
New Drug Combo for ALS Slows Decline in Small Clinical Study

After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.

After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.

neurodegenerative diseases
Advancing Disease Research with Mass Spectrometry
Advancing Disease Research with Mass Spectrometry
The Scientist Creative Services Team | Sep 15, 2020
Explore just how indispensible mass spectrometry is becoming to life science researchers.
Flu and Pneumonia Vaccines Linked to Reduced Risk of Alzheimer’s
Flu and Pneumonia Vaccines Linked to Reduced Risk of Alzheimer’s
Amanda Heidt | Jul 27, 2020
The authors propose that the shots might keep the immune system primed to battle diseases that would otherwise contribute to cognitive decline.
Astrocyte-to-Neuron Method Reverses Neurodegeneration in Mice
Astrocyte-to-Neuron Method Reverses Neurodegeneration in Mice
Ruth Williams | Jun 24, 2020
The cell conversion strategy restores neurons and motor functions lost as a result of an induced Parkinson’s-like illness in the animals.
Variants in Water Channel Gene Tied to More Restful Sleep
Variants in Water Channel Gene Tied to More Restful Sleep
Abby Olena | May 12, 2020
The gene, aquaporin-4, is critical in rodents for the cerebrospinal fluid bath the brain gets during sleep. It’s now also tied to slow wave electrical activity during deep sleep in people.
<em>The Scientist&nbsp;</em>Infographics: Editor&rsquo;s Picks of 2019
The Scientist Infographics: Editor’s Picks of 2019
Jef Akst | Dec 18, 2019
This year’s most beautiful illustrations covered topics including the molecular underpinnings of Parkinson’s disease and strategies for tracking marine organisms around the world’s oceans.
Interactive: Biomarkers in Blood Provide a Window into the Brain
Interactive: Biomarkers in Blood Provide a Window into the Brain
Shawna Williams | Dec 1, 2019
A look at some of the circulating molecules that may indicate various Alzheimer’s pathologies and serve as the bases of noninvasive tests for the disease.
The Hunt for a Blood Test for Alzheimer&rsquo;s Disease
The Hunt for a Blood Test for Alzheimer’s Disease
Shawna Williams | Dec 1, 2019
Researchers hope circulating biomarkers will enable earlier detection and better monitoring of the neurodegenerative disorder—and perhaps help usher in new treatments.
Is It Time to Rethink Parkinson&rsquo;s Pathology?
Is It Time to Rethink Parkinson’s Pathology?
Ashley Yeager | Oct 1, 2019
New evidence points to a waste-clearing problem in patients’ cells, rather than the accumulation of protein tangles, as the root cause of the neurodegenerative disease.
Infographic: How Air Pollution Could Affect the Brain
Infographic: How Air Pollution Could Affect the Brain
Catherine Offord | Oct 1, 2019
Evidence is accumulating that breathing contaminated air might impair cognition.